Corona Remedies acquires antiseptic brand Wokadine from Dr Reddy’s to enter Iodine market
This strategic acquisition enables CORONA Remedies to penetrate deeper into targeted specialty and offer wider accessibility
This strategic acquisition enables CORONA Remedies to penetrate deeper into targeted specialty and offer wider accessibility
The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market
Subscribe To Our Newsletter & Stay Updated